End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

Reset all filters
01 2ACTEMRA
02 1ADREVIEW
03 1AMELUZ
04 1ARISTADA
05 1ARISTADA INITIO KIT
06 1ASPARLAS
07 1CARNEXIV
08 1CELESTONE SOLUSPAN
09 1KRYSTEXXA
10 1LORATADINE
11 1MECLIZINE HYDROCHLORIDE
12 1MELOXICAM
13 1ONCASPAR
14 2PEGINTRON
15 1SYLATRON
16 1TIMOLOL
17 1TIMOLOL MALEATE
18 1VERSACLOZ
19 1ZIOPTAN
Reset all filters
01 114602
02 121530
03 122290
04 176805
05 177259
06 1103411
07 3103949
08 1125276
09 1125293
10 1125472
11 1200432
12 1202514
13 1203479
14 1205309
15 1206030
16 1207533
17 1208081
18 1209830
19 1761102
Reset all filters
01 15No
02 6Yes
Drug : KRYSTEXXA
Dosage Form : INJECTABLE; INJECTION
Application Number : 125293
Country : US
Patented : No




Drug : TIMOLOL
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 205309
Country : US
Patented : No

Drug : ASPARLAS
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 761102
Country : US
Patented : No

